Long term supporter of the company and SI.
Posting for first time.
I want to believe there should be a good reason for FDA to do what they did.
Could it be- That once approved for one indication, and in the hospital shelves, FDA is worried, doctors would be tempted (for good reason) to use it (off-label) for COVID-ARDS?
This could have implications for not only - Use without full evidence, supply constraints for the indication approved, manufacturing capacity not ready, etc.
So this could be a way to buy time, while they get more evidence for COVID use, which is probably their number 1 worry at the moment.
If it is, I am still positive.
Just delays my personal plans a little bit.
Not that I was in a rush to sell.
Long term supporter of the company and SI.Posting for first...
-
- There are more pages in this discussion • 313 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.025(2.29%) |
Mkt cap ! $1.216B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.10 | $1.06 | $4.942M | 4.613M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 70659 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 43531 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |